David Fabi, MD
Adult Reconstructive Orthopaedic Surgery · San Diego, CANPI 1326240805
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 71.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $137,123 and has fallen 99.6% since, to $538 in 2025.
Across 297 payments — averaging $847.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$180K
- Microport Orthopedics Inc$28K
- Encore Medical, LP$26K
- Vertex$8K
- DJO, LLC$2K
- Stryker$2K
- plus $5K from 18 others
Across 31 payments — averaging $3177.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$52K
- Microport Orthopedics Inc$46K
What the payments were for
- Consulting fees$70,78228%
- Speaking & faculty fees$125,68950%
- Travel & lodging$48,35819%
- Food & beverage$6,9293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 148 | $180,088 |
| Microport Orthopedics Inc | 62 | $27,675 |
| Encore Medical, LP | 28 | $26,097 |
| Vertex | 6 | $8,477 |
| DJO, LLC | 5 | $2,133 |
| Stryker | 11 | $1,889 |
| Orthosensor Inc. | 1 | $1,500 |
| Heraeus Medical, LLC. | 6 | $1,415 |
| Insight Medical Systems, Inc. | 3 | $828 |
| Zimmer Biomet | 8 | $446 |
| Hikma Pharmaceuticals USA | 1 | $344 |
| Restor3d, Inc. | 4 | $296 |
| Bone Support Inc. | 1 | $130 |
| Orthalign Inc | 1 | $120 |
| Onkos Surgical, Inc. | 1 | $89 |
| Naviswiss, Inc. | 1 | $37 |
| Johnson & Johnson | 2 | $36 |
| Davol Inc. | 2 | $35 |
| Conmed Corporation | 1 | $31 |
| BD | 1 | $29 |
| Organogenesis Inc. | 1 | $20 |
| Bioventus LLC | 1 | $17 |
| Pajunk Medical Systems, LP | 1 | $14 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Navio Surgical System$105,481
- DJO SURGICAL$43,824
- Journey II$43,766
- Journey II XR$37,197
- REAL INTELLIGENCE$34,088
- Legion Revision$27,540
- Journey II BCS$26,207
- JII Unicondylar Knee System$25,978
- Tandem$18,875
- MPO Hip System$18,508
- Journey Uni$17,207
- Journey II CR$13,781
- OR3O Dual Mobility$13,198
- Legion$12,731
- REDAPT$6,929
- ZUK Uni$6,375
- Stride Unicondylar Knee System$6,375
- Legion Hinge$6,375
- Anthology$5,175
- DJO Surgical FMP Acetabular System$4,875
How this compares
$251,758 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $17,053 |
| Celecoxib | 157 | $3,850 |
| Gabapentin | 159 | $1,191 |
| Doxycycline Hyclate | 158 | $964 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $431 |
| Amoxicillin | 99 | $149 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $103 |
| Meloxicam | 33 | $69 |
| Methylprednisolone | 13 | $60 |
| Clindamycin Hcl | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in San Diego
- Krishna CidambiSan Diego$51K
- Thomas HongSan Diego$34K
- Chihua LeeSan Diego$16K
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.